Sin-Ae Lee

Title: Innovations of Sin-Ae Lee in Anti-Cancer Research

Introduction

Sin-Ae Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of anti-cancer research, particularly through his innovative methods for screening anti-cancer compounds. With a total of two patents to his name, Lee's work is paving the way for new treatments in cancer therapy.

Latest Patents

Lee's latest patents focus on a method for screening anti-cancer compounds that inhibit the function of the transmembrane 4 L6 family member 5 (TM4SF5) protein. The method involves culturing cancer cells that express TM4SF5, treating these cells with potential anti-cancer candidates, and determining their effectiveness based on their ability to exhibit antagonistic activity against tumor formation and metastasis. Additionally, his patents include the identification of chalcone compounds that demonstrate anti-cancer activity, which can be utilized in effective anti-cancer compositions.

Career Highlights

Throughout his career, Sin-Ae Lee has worked with esteemed institutions such as Seoul National University and the Industry-Academic Cooperation Foundation at Gyeongsang National University. His research has been instrumental in advancing the understanding of cancer mechanisms and developing new therapeutic strategies.

Collaborations

Lee has collaborated with notable colleagues, including Ki Hun Park and Jung Weon Lee, contributing to a rich environment of innovation and research in the field of cancer treatment.

Conclusion

Sin-Ae Lee's innovative approaches to anti-cancer research highlight his dedication to improving cancer therapies. His patents and collaborations reflect a commitment to advancing medical science and providing hope for cancer patients.